Qi Chen Xin
No más puestos en curso
Fortuna: 24 M $ al 31/05/2024
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Chongqing Genrix Biopharmaceutical Co., Ltd.
 Chongqing Genrix Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Chongqing Genrix Biopharmaceutical Co., Ltd. principally engages in the research, development, production, and sale of antibody drugs. Its key antibody drugs are mainly for autoimmune diseases, infectious diseases, and tumors. The company was founded on October 20, 2015 and is headquartered in Chongqing, China. 1.65% | 30/06/2023 | 4 583 300 ( 1.65% ) | 24 M $ | 31/05/2024 |
- Bolsa de valores
- Insiders
- Qi Chen Xin
